Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of May 21, 2026, NEPH trades at $3.57 with a market cap of $39.95M and a P/E ratio of 32.64. NEPH moved -2.34% today. Year to date, NEPH is -26.65%; over the trailing twelve months it is +54.68%. Its 52-week range spans $1.36 to $6.42. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nephros Targets $25M New York Market with New Regional Sales Leader: Nephros appoints Dana Cunningham as regional sales leader for the Greater New York market, which it estimates offers a $25 million annual opportunity in point-of-use filtration and related services. The expansion targets healthcare systems, commercial facilities and channel partners to address waterborne pathogen risk in aging infrastructure under rising regulatory scrutiny.
| Metric | Value |
|---|---|
| Price | $3.57 |
| Market Cap | $39.95M |
| P/E Ratio | 32.64 |
| EPS | $0.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.42 |
| 52-Week Low | $1.36 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $18.79M |
| Net Income | $1.19M |
| Gross Margin | 61.87% |
1 analysts cover NEPH: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.